A Nut for Every Bolt: Subunit-Selective Inhibitors of the Immunoproteasome and Their Therapeutic Potential
At the heart of the ubiquitin–proteasome system, the 20S proteasome core particle (CP) breaks down the majority of intracellular proteins tagged for destruction. Thereby, the CP controls many cellular processes including cell cycle progression and cell signalling. Inhibitors of the CP can suppress t...
Main Authors: | Eva M. Huber, Michael Groll |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/8/1929 |
Similar Items
-
Discovery and Early Clinical Development of Selective Immunoproteasome Inhibitors
by: Christopher J. Kirk, et al.
Published: (2021-12-01) -
Mechanistic and thermodynamic characterization of oxathiazolones as potent and selective covalent immunoproteasome inhibitors
by: Levente M. Mihalovits, et al.
Published: (2021-01-01) -
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
by: Michael Basler, et al.
Published: (2014-01-01) -
Immunoproteasome inhibition attenuates experimental psoriasis
by: Marta del Rio Oliva, et al.
Published: (2022-12-01) -
The role of the immunoproteasome in cardiovascular disease
by: Yifei Nie, et al.
Published: (2024-06-01)